<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>GBIHealth | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-17T11:25:50+08:00</updated>
  <subtitle>GBI专注于中国市场，为药企、器械企业和其他服务提供商建立多元的市场情报解决方案组合。GBI的高附加值行业信息、新闻和数据服务能力帮助个人和组织做出以数据为驱动的决策，更高效地沟通。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>MSD Keytruda获FDA批准；赛诺菲创新药在中国商业上市；信达生物公布IBI302 I期临床结果；百济赴上交所科创板上市</title>
    <updated>2020-11-16T21:12:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/GYDgNldjozJpEMd8czFNzg</id>
    <link href="https://mp.weixin.qq.com/s/GYDgNldjozJpEMd8czFNzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 启明医疗获批中国首个第二代人工瓣膜系统；推想科技肺结节CT影像辅助软件​获NMPA批准</title>
    <updated>2020-11-16T21:12:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/CTF-ejgVEfImpgox5kGntg</id>
    <link href="https://mp.weixin.qq.com/s/CTF-ejgVEfImpgox5kGntg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个新冠灭活疫苗III期临床顺利推进；三款药新适应症上市申请进入优先审评；复星医药临试申请获受理；维迪西妥单抗获快速审批通道资格</title>
    <updated>2020-11-15T22:21:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/gdp8vs-c506_eI-Ayr3QqQ</id>
    <link href="https://mp.weixin.qq.com/s/gdp8vs-c506_eI-Ayr3QqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>在线课堂 |【第40期】卓越的国际多中心临床运营</title>
    <updated>2020-11-15T22:21:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/THx-WBE49dKlpd8RUcbUCQ</id>
    <link href="https://mp.weixin.qq.com/s/THx-WBE49dKlpd8RUcbUCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CphMRA 2020本周四线上线下同步开启 | GBI与您相约第九届中国医药决策科学峰会</title>
    <updated>2020-11-15T22:21:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/W4m8rGv6uQa5hA_vQTNgHg</id>
    <link href="https://mp.weixin.qq.com/s/W4m8rGv6uQa5hA_vQTNgHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药企36计  医保目录调整风口，究竟是谁在带节奏</title>
    <updated>2020-11-13T23:53:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/ZZPBME410RHsQ9FdSCYOqw</id>
    <link href="https://mp.weixin.qq.com/s/ZZPBME410RHsQ9FdSCYOqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>联合国糖尿病日 | 危险！你会成为十中之一吗</title>
    <updated>2020-11-13T23:53:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/FUSpjBPVyrWt-zGE2YofbQ</id>
    <link href="https://mp.weixin.qq.com/s/FUSpjBPVyrWt-zGE2YofbQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>联合国糖尿病日 | 危险！你会成为十中之一吗</title>
    <updated>2020-11-12T23:13:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/sgwRSCoWA14_mz9KwbRxfw</id>
    <link href="https://mp.weixin.qq.com/s/sgwRSCoWA14_mz9KwbRxfw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>巴西恢复科兴新冠疫苗试验；默沙东PD-1抑制剂拟纳入优先审评；强生CD38单抗拟纳入优先审评；基石药业获NMPA受理上市申请</title>
    <updated>2020-11-12T23:13:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/-y1fFcGPxiMT2vKJ1PsNRg</id>
    <link href="https://mp.weixin.qq.com/s/-y1fFcGPxiMT2vKJ1PsNRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>可查！国家医保药品目录调整申报系统可查询评审结果(含调整展望及重点公司影响分析)</title>
    <updated>2020-11-12T23:13:41+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/0i9USrkJaEO5R0Ud3lrVDw</id>
    <link href="https://mp.weixin.qq.com/s/0i9USrkJaEO5R0Ud3lrVDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MPS I 特异性治疗时代来了！注射用拉罗尼酶浓溶液中国上市会成功举办！</title>
    <updated>2020-11-11T21:11:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/5Eijf1_dY2V6Vbc-hHfTaA</id>
    <link href="https://mp.weixin.qq.com/s/5Eijf1_dY2V6Vbc-hHfTaA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>罗氏首次在华启动CD3×CD20双抗Glofitamab临床试验；思路迪获Aravive旗下抗肿瘤新药大中华区独家权益</title>
    <updated>2020-11-11T21:11:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/SfnzxzJTA4XxP9cDSuLSTA</id>
    <link href="https://mp.weixin.qq.com/s/SfnzxzJTA4XxP9cDSuLSTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最高降80%？国家质量监管来了 | 以后不怕给孩子辅导作业了</title>
    <updated>2020-11-11T21:11:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/iMB1uskIUbjh38y1GCqQrg</id>
    <link href="https://mp.weixin.qq.com/s/iMB1uskIUbjh38y1GCqQrg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 年许可交易纵览，国内生物技术公司进军国际</title>
    <updated>2020-11-10T17:39:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/NrbZGLavCi6jt16bMhrLSQ</id>
    <link href="https://mp.weixin.qq.com/s/NrbZGLavCi6jt16bMhrLSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GSK与中国癌症基金会合作；中国新冠疫苗巴西、墨西哥待遇大相径庭；赛诺菲BTK抑制剂获临床默示许可；礼来获FDA紧急使用授权</title>
    <updated>2020-11-10T17:39:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/2NE92JHceSccvCSPFFrpOw</id>
    <link href="https://mp.weixin.qq.com/s/2NE92JHceSccvCSPFFrpOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>带量采购：械企报价，这些问题亟需注意</title>
    <updated>2020-11-10T17:39:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/2DYpHpI4I0mAojHQLH9aCQ</id>
    <link href="https://mp.weixin.qq.com/s/2DYpHpI4I0mAojHQLH9aCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>进博会&lt;交易&gt;集锦 | “未来工厂”+基层医疗服务强化+技术升级</title>
    <updated>2020-11-09T22:00:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/rHPhiqclf8mkpPgMe0Kejg</id>
    <link href="https://mp.weixin.qq.com/s/rHPhiqclf8mkpPgMe0Kejg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞和BioNTech宣布新冠疫苗90％有效；Assembly药物II期临床失利；卫材进入甲状腺癌市场；阿斯利康携手瑞士欧姆制药</title>
    <updated>2020-11-09T22:00:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/VadpxLPyCKKVNIUuw4QFWw</id>
    <link href="https://mp.weixin.qq.com/s/VadpxLPyCKKVNIUuw4QFWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>DEVINT | 携手创新 下沉回报 合作共赢！</title>
    <updated>2020-11-09T22:00:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-09:/s/3dAF6LQY04THvmvR6u0JSQ</id>
    <link href="https://mp.weixin.qq.com/s/3dAF6LQY04THvmvR6u0JSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>遭FDA独立专家会全面否决药物仍有机会获FDA批准；数字药品APP获批上市将影响诊疗路径；阿斯利康与博鳌乐城达成多项合作</title>
    <updated>2020-11-08T19:30:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-08:/s/V3G4VRSkrsz6Cdcf3l9_4Q</id>
    <link href="https://mp.weixin.qq.com/s/V3G4VRSkrsz6Cdcf3l9_4Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>